experimental vaccine

BIOLOGICAL8 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention, Sinovac Biotech Co., Ltd, Hualan Biological Bacterin Co. Ltd.

Conditions

Epidemic MeningitisHand, Foot and Mouth DiseaseMeningococcal VaccinesPoliomyelitisRabies HumanVaccine

Phase 3

Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese

CompletedNCT03714737

Jiangsu Province Centers for Disease Control and PreventionVaccine

Start: 2016-05-12End: 2018-09-06Updated: 2018-10-22

Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

CompletedNCT05386810

Sinovac Biotech Co., LtdPoliomyelitis

Start: 2020-11-05End: 2023-07-20Updated: 2024-04-15

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

CompletedNCT06177249

Hualan Biological Bacterin Co. Ltd.Rabies Human

Start: 2015-03-15End: 2016-05-01Updated: 2023-12-20

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months

Not yet recruitingNCT07505810

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2028-01-01Target: 880Updated: 2026-04-01

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Not yet recruitingNCT07505836

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2027-01-01Target: 1040Updated: 2026-04-01

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years

Not yet recruitingNCT07505888

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2026-11-01Target: 660Updated: 2026-04-01

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months

Not yet recruitingNCT07505823

Sinovac Biotech Co., LtdEpidemic Meningitis, Meningococcal Vaccines

Start: 2026-03-22End: 2028-01-01Target: 1040Updated: 2026-04-01

Phase 4

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

Sinovac Biotech Co., LtdHand, Foot and Mouth Disease

Start: 2022-07-30End: 2025-10-30Target: 474Updated: 2022-06-10